FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 3241293 · Received July 22, 2013

Report

Report Number
1416980-2013-19339
Event Type
Injury
Date Received
July 22, 2013
Date of Event
June 22, 2013
Report Date
June 27, 2013
Manufacturer
BAXTER HEALTHCARE
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). FIFTEEN DAY AFTER THE ONSET OF PERITONITIS, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL AND THE TREATMENT WITH LEVOFLOXACIN AND HEPARIN WAS DISCONTINUED. AT THE TIME OF THIS REPORT THE PATIENT WAS RECOVERED FROM PERITONITIS. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). AS THE SAMPLE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN, A DEVICE ANALYSIS CANNOT BE COMPLETED. BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

THIS IS A REPORT OF A PATIENT WHO EXPERIENCED AND WAS HOSPITALIZED FOR PERITONITIS COINCIDENT WITH THERAPY FOR PERITONEAL DIALYSIS. THERAPY WAS ONGOING. THE PATIENT EXPERIENCED ABDOMINAL PAIN AND CLOUDY EFFLUENT AS A RESULT OF THE PERITONITIS. THE PATIENT WAS TREATED WITH LEVOFLOXACIN 0.04 G IP THREE TIMES A DAY AND HEPARIN 1000 UNITS IP THREE TIMES A DAY. AT THE TIME OF THIS REPORT, THE PATIENT WAS RECOVERING FROM THE PERITONITIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
341788 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE

Patients

Seq Age Sex Outcome Treatment
1 34 YR Hospitalization| R POLYSACCHARIDE-IRON COMPLEX, NIFEDIPINE| DIANEAL PD2, ASPIRIN, FOLIC ACID, LOSARTAN